Udg Healthcare Public Share Discussion Threads

[3rd eye] 03/6/2020 12:33

UDG Healthcare........... Interesting to see the forward forecast for the company. As per the majority of stock it will take a (very small) hit for 30/09/2020 but then in 2021 bounces back with vengeance, with a 16% rise in EPS which would put it on a p/e of 17 and a PEG of 1........in other words a (late) Jim Slater ZULU principle stock. SEE forward forecasts below. FORECAST year Ending Revenue (€m) Pre-tax(€m) EPS P/E PEG EPS Growth Div Yield 2020-09-30 1,005.48 102.04 36.88p 20.1 -4.8 -4% 11.18p 1.5% 2021-09-30 1,087.20 122.83 42.91p 17.1 1.0 16% 15.01p 2.0% CHART SP as moved above the 200 day moving average a bullish sign. In a lovely uptrend.

[3rd eye] 22/5/2020 09:29

UDG Broker Forecasts.......... Latest broker views Date Broker Recomm. Current Price Price when issued Old price New price 22 May 20 Berenberg Buy 692.50 694.00 740.00 880.00 19 May 20 Liberum Capital Buy 692.50 623.50 900.00 - 19 May 20 Peel Hunt Buy 692.50 623.50 1,165.00

[3rd eye] 22/5/2020 09:12

UDG Healthcare UDG.. worth a bob or two investment. UDG valuation is ‘compelling217;, says Berenberg Healthcare packaging company UDG Healthcare (UDG) is trading on a ‘compelling valuation’ for a market leader, says Berenberg. Analyst Eoghan Read retained his ‘buy’ recommendation and increased his target price from 740p to 880p. The shares rose 1.6% to 692.5p yesterday. First-half results from the group beat Read’s forecasts by 6% and he said while it had not been immune from the impact of Covid-19, his ‘confidence in the equity story’ had increased thanks to positive momentum, operating resilience, and the ‘long-term structural drivers evident in the market’. ‘UDG remains one of our top picks in our UK mid-cap business services coverage,’ he said. ‘Trading on a 20% discount to long-term average and US peers, we think it now presents a compelling valuation opportunity for a structurally growing and market-leading operator.’ ============================================================================ Lovely uptrend channel on the chart. If it breaks through the ceiling of the channel, next share price target mid term is 730p approx. P/E 19 for 2021, cheap considering the Boom in Bios and health at the moment.

[brain smiley] 17/3/2020 15:47

Come on; put out the profit warning !

[brain smiley] 31/1/2020 16:20

UDG organises meeting and events for the drugs industry in China.Will they have to be cancelledand how much profit do they make from them ?

[our haven] 28/1/2020 07:20

Another good update. Well ahead of their previous trading quarter. I'd say we can have confidence going forward, US business going well.

[our haven] 26/11/2019 07:26

Results look solid. Not sure how the opening will go but I suspect negative initial reaction. However longer term should be okay.

[prandhawa] 09/10/2019 11:50

Ootmjuujookikikkkkkkkjj

[our haven] 21/5/2019 07:39

Take overs being well received by the market particularly the US takeover.Looks a good piece of business for UD.

[hyper ai] 04/4/2019 13:30

time to go short again. great down-trend.

[mfhmfh] 02/4/2019 14:25

Peel Hunt today reitrratr buy rating and 1,030 target price.

[brain smiley] 26/3/2019 10:33

Interesting price action;hit 5.45 this morning. Mmmm.

[brain smiley] 14/3/2019 14:21

What a dog;next results will be interesting.

[gswredland] 09/3/2019 09:52

Seems to bounce back from 560

[mfhmfh] 04/3/2019 09:46

positive write-up in last week's Shares Magazine

[hyper ai] 19/2/2019 15:32

downtrend still in place

[brain smiley] 19/2/2019 14:55

Very poor performer.Shorttracker showing a Fund opened a 1.1% short in February;the only short interest in UDG. Wouldn't be surprised to see more director buying.

[mfhmfh] 04/2/2019 09:56

'Erik Van Snippenberg, Non Executive Director, bought 7,500 shares in the company on the 1st February 2019 at a price of 587.00p. The Director now holds 7,500 shares representing 0.00% of the shares in issue.'

[mfhmfh] 30/1/2019 09:50

buy rating reiterated in yesterday's IC

[mfhmfh] 29/1/2019 12:20

Peel Hunt today reiterates buy rating and 1,030p target price.

[mfhmfh] 29/1/2019 12:13

future acquisitions a possibility: 'The Group's strong balance sheet leaves it well placed to make further strategic acquisitions as those opportunities arise, complementing its continued underlying profit growth.'

[mfhmfh] 29/1/2019 12:10

great update today IMHO: 'The Group has made a good start to the financial year with constant currency profit before tax for the quarter to 31 December 2018 well ahead of the same quarter last year, and in-line with the Group's previously communicated expectations. This performance has been driven by good underlying growth supplemented by the impact of acquisitions completed in FY18.' 'Ashfield's operating profit was ahead of the same quarter last year. ' 'Sharp's operating profit was significantly ahead of the same quarter last year. '

[soundbuy] 11/1/2019 10:27

Jefferies International Hold 581.75 626.50 Old PT: 765.00 New PT:620.00 Downgrades There's your answer...

[brain smiley] 11/1/2019 10:21

Big drop ....